Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 26
Phase 310

Trial Status

Completed11
Recruiting3
Other3

Role Distribution

Principal Investigator17
PI Rate100%

Activity Timeline

Clinical Trials (17)

NCT07402213Phase 3Recruiting
Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.
Chronic Spontaneous Urticaria
PrincipalinvestigatorStart date: 2026-03-09
NCT06947980Phase 2Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
PrincipalinvestigatorStart date: 2025-06-19
NCT07712731Phase 3Completed
HPP737 in Adult Patients With Plaque Psoriasis
Psoriasis
PrincipalinvestigatorStart date: 2025-04-18
NCT06495229Phase 3Active Not Recruiting
Study of CM310 in Adolescent Subjects With Atopic Dermatis
Atopic Dermatitis
PrincipalinvestigatorStart date: 2024-08-02
NCT06277765Phase 3Completed
Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis
Atopic Dermatitis
PrincipalinvestigatorStart date: 2024-03-21
NCT06277245Phase 3Completed
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
Atopic Dermatitis
PrincipalinvestigatorStart date: 2024-02-06
NCT06278350Phase 2Completed
Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
PrincipalinvestigatorStart date: 2024-01-31
NCT07712705Phase 3Completed
HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.
Psoriasis
PrincipalinvestigatorStart date: 2023-04-20

Showing 10 of 17 trials

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Qinping Yang

Huashan Hospital

Related
2 trials

Shared therapeutic areas:

Androgenetic AlopeciaAndrogenetic Alopecia (AGA)

Worked with same sponsors:

Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.
Collaborated on 2 trials
Similarity Score28%

David Berk, MD

Arcutis Biotherapeutics, Inc.

Related
17 trials

Shared therapeutic areas:

Plaque PsoriasisPsoriasisDermatitis, Atopic
Similarity Score15%

Robert Bissonnette, MD

Innovaderm Research Inc.

Related
15 trials

Shared therapeutic areas:

Dermatitis, AtopicPlaque PsoriasisPsoriasis
Similarity Score15%

Xinghua Gao

First Hospital of China Medical University

Related
5 trials

Shared therapeutic areas:

Dermatitis, AtopicPsoriasis

Worked with same sponsors:

Keymed Biosciences Co.Ltd
Similarity Score10%

Peter Wolf, MD

Medical University of Graz

Related
13 trials

Shared therapeutic areas:

PsoriasisDermatitis, Atopic
Similarity Score10%

Robert Bissonnette, MD

Innovaderm Research

Related
10 trials

Shared therapeutic areas:

PsoriasisDermatitis, Atopic
Similarity Score10%

Dr. Nayan K Patel

NovoBliss Research Pvt Ltd

Related
14 trials

Shared therapeutic areas:

Androgenetic AlopeciaDermatitis, Atopic
Similarity Score10%

Guoqiang Zhang

The First Hospital of Hebei Medical University

Related
2 trials

Shared therapeutic areas:

Dermatitis, AtopicPsoriasis
Similarity Score10%

SELIM ARACTINGI

HOPITAL COCHIN - PARIS

Related
2 trials

Shared therapeutic areas:

Chronic Spontaneous UrticariaPsoriasis
Similarity Score10%

Ronald W Gottschalk, MD

Galderma R&D

Related
19 trials

Shared therapeutic areas:

Plaque PsoriasisPsoriasis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (17)

Showing 17 of 17 trials

NCT07402213Phase 3PrincipalInvestigator

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria
Recruiting
NCT06947980Phase 2PrincipalInvestigator

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
Recruiting
NCT07712731Phase 3PrincipalInvestigator

HPP737 in Adult Patients With Plaque Psoriasis

Psoriasis
Completed
NCT06495229Phase 3PrincipalInvestigator

Study of CM310 in Adolescent Subjects With Atopic Dermatis

Atopic Dermatitis
Active Not Recruiting
NCT06477835Phase 3PrincipalInvestigator

A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Completed
NCT06277765Phase 3PrincipalInvestigator

Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Atopic Dermatitis
Completed
NCT06277245Phase 3PrincipalInvestigator

A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis
Completed
NCT06278350Phase 2PrincipalInvestigator

Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis
Completed
NCT07712705Phase 3PrincipalInvestigator

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

Psoriasis
Completed
NCT05531682Phase 2PrincipalInvestigator

A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis
Completed
NCT05265923Phase 3PrincipalInvestigator

A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis
Completed
NCT06085521Phase 2PrincipalInvestigator

A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Completed
NCT04839328Phase 3PrincipalInvestigator

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis
Completed
NCT06126965Phase 3PrincipalInvestigator

Phase III Study of KX-826 With Adult Male Patients With AGA

Androgenetic Alopecia
Unknown
NCT05023668PrincipalInvestigator

China Atopic Dermatitis Registry Study

Dermatitis, Atopic
Unknown
NCT05940506Phase 2PrincipalInvestigator

Phase II Study Evaluating the Efficacy and Safety of KX-826

Androgenetic Alopecia (AGA)
Completed
NCT07230483Phase 2PrincipalInvestigator

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Atopic Dermatitis (AD)
Recruiting

All 17 trials loaded